嗜碱性粒细胞
免疫球蛋白E
中和
过敏
免疫学
化学
纳米颗粒
病毒学
纳米毒理学
抗体
嗜碱性粒细胞活化
免疫系统
免疫血清
医学
作者
Cuiye Weng,Xinyi Xu,Huixi Tu,Zheng Wang,Xinlong Jin,Xuewei Yang,Dongyan Tian,Xufei Zhang,Deli Zhuge,Mengchun Chen,Yijie Chen,Weixi Zhang
标识
DOI:10.1186/s12951-026-05060-3
摘要
Immunoglobulin E (IgE) is a key mediator of allergic diseases, and its dysregulation can trigger systemic anaphylaxis and even be fatal. Despite its clinical importance, therapeutic options for safe and effective IgE neutralization remain limited. Here, we developed basophil membrane-coated nanoparticles (BMNPs) as a biomimetic strategy to sequester IgE. BMNPs were engineered by cloaking poly (lactic-co-glycolic acid) (PLGA) cores with RBL-2H3 cell (basophilic leukemia cell line)-derived membranes, preserving surface proteins such as FcεRI. These nanoparticles displayed selective IgE binding, competitively preventing IgE from engaging FcεRI on mast cells and thereby inhibiting degranulation upon allergen exposure. This led to decreased histamine and β-hexosaminidase release, lower Th2 cytokine levels (IL-4, IL-13), and attenuated Ca 2+ signaling and ERK/p38 activation as downstream consequences of reduced degranulation. In murine models of passive cutaneous and active systemic anaphylaxis, intravenously administered BMNPs effectively reduced circulating IgE, reduced vascular hyperpermeability, suppressed mast cell degranulation, and limited inflammatory cell infiltration. Transcriptomic profiling further indicated that BMNP-mediated IgE neutralization attenuates Ca 2+ influx and downregulates NF-κB, MAPK, and other proinflammatory pathways as downstream consequences of reduced mast cell degranulation in allergic regions. Importantly, BMNPs demonstrated favorable in vivo biosafety. Together, these results establish BMNPs as a safe and effective nanoplatform for IgE neutralization and suppression of IgE-mediated allergic responses, offering a promising therapeutic strategy for allergic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI